罗欣药业: 关于控股股东部分股份质押及解除质押的公告

Core Viewpoint - The announcement details the pledge and release of shares by the controlling shareholder of Luoxin Pharmaceutical Group Co., Ltd., indicating changes in shareholding structure and potential implications for the company's financial health and governance [1][2]. Share Pledge Situation - Luoxin Holdings, the controlling shareholder, pledged 25,000,000 shares, accounting for 10.55% of its holdings and 2.30% of the total shares of the company [1]. - The purpose of the pledge is for capital turnover, with the pledge starting on July 17 and set to expire on an unspecified date [1]. Share Release Situation - Luoxin Holdings released 16,500,000 shares from pledge, which represents 6.96% of its holdings and 1.52% of the total shares of the company [1]. - The release occurred on August 18, with the shares previously pledged starting from an unspecified date [1]. Cumulative Pledge Situation - As of the announcement date, the total pledged shares by Luoxin Holdings and its concerted parties amount to 102,443,530 shares, which is 43.23% of the shares held by the controlling shareholder and 9.42% of the total shares of the company [2]. - The corresponding financing balance for these pledged shares is 172.5 million yuan [2]. Financial Health of Shareholders - The controlling shareholder and its concerted parties are reported to have a good credit status and possess the financial capability to repay the pledged amounts [2].